The healthcare and life sciences (HLS) landscape has been on the cusp of dramatic transformation for the last couple of years, on account of widespread regulatory changes and evolving business models. The expectation was to have robot doctors, personalized medicine/therapies, cheaper & faster drug trials, seamless integration between care financials/delivery/management, end-to-end digitization of the care experience, and a true value-based care model. Although, changes are underway, albeit at varying pace, the endemic issues of healthcare still remain, the three Cs – Cost, Compliance, and Consumerization. This shows that the needle on these systemic themes has not moved meaningfully enough and there is still a lot of ground to cover. Consumers are assuming greater ownership, control, and responsibility of their health outcomes. The decision making is shifting to the individual and patient engagement, as population health management remains the key to improving care outcomes, enhancing care experience, and trimming costs. This is meaningfully impacting how healthcare stakeholders and service providers approach technology and business process sourcing in terms of deal constructs, focus themes, consumption models, and service dynamics.
In the midst of this evolving HLS landscape (both from the demand and supply side) as well as a services landscape in transition, this report looks at identifying the opportunities, quantifying the market size, comprehending the competitive dynamics, and analysing the key themes for 2016.
Note: this report is from 2012. See our most recent R2R research report.
The Finance & Accounting (F&A) function comprises three end-to-end processes – Procure-to-Pay (P2P), Order-to-Cash (O2C), and Record-to-Report (R2R). This report focuses on…
